In line, several studies have demonstrated that inhibition of the nSMase enzyme, which acts among other processes on the exosome generation, decreases the spreading of Tau and Aβ pathologies as well as other AD-related phenotypes including glial inflammation and cognitive defects [73,164]. This evidence concerns the gene MAPT and Alzheimer disease.